Extending the time for thrombolysis in emergency neurological deficits – intra-arterial with tenecteplase

Lead PI: Dr Bruce Campbell

Status: Closed

 No. of Patients Currently Recruited: 53                                No. of Patients Required:  tbc

Rapid reperfusion is the key to improved ischemic stroke outcomes. Tenecteplase may be safer and more effective than alteplase. The hypothesis of the EXTEND-IA TNK randomised trial is that intravenous tenecteplase will achieve reperfusion prior to cerebral angiography more frequently than intravenous alteplase in patients eligible for clot retrieval.

Trial URL:

Clinicaltrials.gov NCT02388061

24 June 2021